ODYSSEY trial:  COVID-19 response and CROI update

ODYSSEY trial: COVID-19 response and CROI update

The COVID-19 pandemic is affecting people and health services around the world. Many of the healthcare professionals involved with the ODYSSEY trial have been providing care to patients with COVID-19 in hospitals, clinics and communities and dealing with the public...

ODYSSEY to be presented at CROI 2020

Results from the ODYSSEY trial will be presented at this year’s Conference on Retroviruses and Opportunistic Infections (CROI) in Boston, USA. The trial team’s abstract titled “Adequate dolutegravir exposure dosed bid with rifampicin in children 6 to <18 years” has...

Recruitment to the main trial is complete!

Recruitment to the main trial is complete! The ODYSSEY study has reached a major milestone by completing the recruitment of participants to the main trial. Recruitment of children ≥14kg is complete with a total of 707 participants randomised altogether: 311 recruited...